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1150Objectives:We evaluated results of an echocardiographically based strategy combining mitral annuloplasty with
other procedures to treat chronic ischemic mitral regurgitation.
Methods: FromMarch 2006 to February 2009, 147 patients underwent mitral valve surgery for chronic ischemic
mitral regurgitation. Mean effective regurgitant orifice was 36 11 mm2, and ejection fraction was 35% 9%.
On the basis of echocardiographic findings, in 10 cases a prosthesis was inserted and mitral annuloplasty was
performed in 137 cases, isolated in 83, associated with chordal cutting in 12 cases (in 5 anterior leaflet was aug-
mented with pericardial patch), and with exclusion of anteroseptal (n ¼ 35) or inferior (n ¼ 7) scars in 42.
Results: Thirty-day mortality was 4.8%; 3-year survival was 86% 3%. None of the 126 survivors were in New
York Heart Association functional class III or IV. Among 117 survivors of mitral valve repair, after 18  6
months mean effective regurgitant orifice reduced from 34.1  10.2 mm2 to 2.3  0.4 mm2 (P<.001). Nine pa-
tients showed residual effective regurgitant orifice 10 to 19 mm2. Reverse remodeling was present in 69 patients
(59.0%), no remodeling in 40 (34.1%), and continuous remodeling in 8 (6.9%). Ejection fraction changed from
37%  10% to 43%  10% (P<.001), improving in 47, remaining unchanged in 63, and worsening in 7.
Conclusions: Echocardiographically based strategy contributed to reduced postoperative mitral regurgitation
persistence (effective regurgitant orifice 10 mm2 in 7.7% of cases, with no patients showing effective regurgi-
tant orifice20mm2). All patients remained in NewYork Heart Association functional class I or II, but more than
mitral annuloplasty was performed in close to 40%. (J Thorac Cardiovasc Surg 2011;141:1150-6)Supplemental material is available online.
Video clip is available online.
Treatment of chronic ischemic mitral regurgitation (CIMR)
still remains a challenge. Results from the literature are not
uniform, and principles of surgical treatment are not clearly
stated. In particular, there is no agreement as to either devices
to be used (ring, band, rigid, semirigid, flexible, shaped, un-
shaped, and so on) or which patients \can benefit from mitral
valve (MV) surgery. Furthermore, many articles report expe-
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The Journal of Thoracic and Cardiovascular Surphysiology of the MV and of the pathophysiology of
CIMR was not complete. Suboptimal results also reflect
lack of standardization of surgical strategies.1-4 We report
here our recent experience, in which surgical treatment of
CIMR was not limited to annuloplasty alone and different
strategies were applied according to echocardiographic data.
MATERIALS AND METHODS
From March 2006 to February 2009, a total of 147 patients underwent
their first cardiac procedure, MV surgery for CIMR caused by inferior
(n ¼ 110, 81%) or anterior (n ¼ 37, 19%) myocardial infarction. Only pa-
tients in cardiogenic shock when operated on were excluded.
Definition
CIMR is defined as any mitral regurgitation that is due to excess of teth-
ering of either or both leaflets as a result of misalignment of either or both of
the papillary muscles. All the patients in this series had a previous myocar-
dial infarction with regional wall abnormalities.
Echocardiographic Evaluation
In all cases, the following data were evaluated: intercommissural and
septolateral distances (systolic and diastolic), ratio of septolateral to inter-
commissural distance (systolic), length of anterior leaflet (AL), tenting
area, coaptation depth (CD), coaptation length (CL), left ventricular indexed
end-systolic volume (ESV) and end-diastolic volume, ejection fraction
(EF), and sphericity index. The mitral annulus was assessed in apical
long-axis 4- and 2-chamber views. The distance between the points where
MV leaflets coapt and mitral annulus plane (CD) was measured at the end
of systole in the 4-chamber apical long-axis view. The mitral areas in dias-
tole and systole were calculated as the MV were an ellipsoid (p/4$SL$IC),
where SL represents the septolateral distance and IC the intercommissuralgery c May 2011
TABLE 1. Preoperative echocardiographic data (n ¼ 147)
End-diastolic volume (mL/m2, mean  SD
and median)
83  25 (82)
End-systolic volume (mL/m2, mean  SD
and median)
55  21 (54)
Ejection fraction (%, mean  SD and median) 35  9 (35)
Ejection fraction 30% (no.) 52 (35.4%)
Sphericity index (mean  SD and median) 0.63  0.10 (0.6)
Mitral regurgitation effective regurgitant
orifice (mm2)
Mean  SD and median 36  11 (34)
1–9 mm2 (no.) 5 (3.5%)
10–19 mm2 (no.) 18 (12.2%)
20 mm2 (no.) 124 (84.3%)
Diastolic intercommissural diameter
(mm, mean  SD and median)
34  3 (33)
Systolic intercommissural distance (mm, mean  SD
and median)
32  3 (31)
Diastolic septolateral diameter (mm, mean  SD
and median)
31  3 (30)
Systolic septolateral diameter (mm, mean  SD
and median)
29  3 (28)
Diastolic mitral area (cm2, mean  SD and median) 8.3  1.4 (8.0)
Systolic mitral area (cm2, mean  SD and median) 7.3  1.3 (7.1)
Mitral area change (%, mean  SD and median) 12  2 (11)
Anterior leaflet length (mm, mean  SD and median) 27  3 (27)
Anterior leaflet length<25 mm (no.) 5 (3.5%)
Septolateral diameter/anterior leaflet length
(mean  SD and median)
1.04  0.12 (1.02)
Coaptation depth (mm, mean  SD and median) 7.9  2.3 (7)
Coaptation length (mm, mean  SD and median) 3.6  1.8 (4)
Tenting area (cm2, mean  SD and median) 1.5  1.0 (1.35)
Tricuspid regurgitation (0–4, mean  SD
and median)
1.5  0.9 (1)
Systolic pulmonary arterial pressure
(mm Hg, mean  SD and median)
36  10 (33)
Abbreviations and Acronyms
AL ¼ anterior leaflet
CIMR ¼ chronic ischemic mitral regurgitation
CD ¼ coaptation depth
CL ¼ coaptation length
EF ¼ ejection fraction
ERO ¼ effective regurgitant orifice
ESV ¼ end-systolic volume
MV ¼ mitral valve
NYHA ¼ New York Heart Association
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DMA$100%, where DMA represents the mitral area during diastole and
SMA that during systole. Left ventricular volumes and EF were measured
according to the biapical Simpson disk method. Evaluation of mitral regur-
gitation grade was performed by using the effective regurgitant orifice
(ERO) to evaluate mitral regurgitation severity, in accordance with Grigioni
and colleagues.5 CIMR was considered severe if ERO was at least 20 mm2,
moderate if ERO was 10 to 19 mm2, and mild if ERO was 1 to 9 mm2.
Table 1 shows the echocardiographic results from the study group.
Surgical Indications
All patients with CIMRwith an ERO of at least 10 mm2 were candidates
for MV surgery. In cases of ERO 1 to 9 mm2, the decision regarding MV
repair depended on the echocardiographically demonstrated MV anatomy.
The median values of septolateral dimension in systole and of the ratio of
systolic septolateral dimension to AL length in patients with ERO of at least
10 mm2 treated during the study time frame were, respectively, 27 mm and
1.02 (Table E1). If either of these values was reached in a patient with ERO
1 to 9 mm2,we hypothesized that the consequence was a dangerous CL
reduction and that surgical treatment was therefore advisable.
A CD of 10 mm or less was the limit for MV repair. If the CD was 11 or
more, the anatomy was not considered suitable for repair, and a prosthesis
was inserted into the MV.6 If the left ventricle was dilated, nuclear magnetic
resonance imaging was performed to evaluate the presence of ventricular
scars to be excluded.
When the MV was suitable for repair, we analyzed the length of the AL
and the presence of AL excess of tethering. Because the purpose of surgery
was to obtain a competent MV with a CL from 4 to 8 mm, we accepted an
AL length of at least 25 mm. If not, we augmented its surface with a pericar-
dial patch. Excess of AL tethering could also be a factor in reduced CL. In
such cases, second-order chordae were cut through an aortotomy. Because
augmentation of AL could also increase second-order chordal tethering, the
second-order chordae were cut every time we augmented the AL surface.
Figure 1 summarizes our algorithm for echocardiographically based sur-
gical indications.
Surgical Technique
After a median sternotomy, the ascending aorta and both venae cavaewere
cannulated, the superior vena cava directly. TheMVwas approached transsep-
tally through a right atriotomy. The mitral annulus was always reshaped with
the SMB40 (Sorin Biomedica SpA, Saluggia, Italy). The band, 40-mm long,
was inserted from A1 (that coincides with the left trigone) to A3 (the fibrous
zone that represents the offshoots of the right trigone) with several interrupted
sutures, leaving the only A2 insertion free (Video E1). Because the surgical
technique is the same for all the annuli, independent of size, all sutures (in
general, 8 to 10) are imbricated to reduce the stress on the single suture.
Insertion of a prosthesis inside theMVwas obtained by cutting only a tri-
angle of the ALwith the base at AL insertion and the apex at the midpoint ofThe Journal of Thoracic and CarA2. The remainder of the AL was pushed toward the annulus with the pros-
thetic sutures.6
Any short (<25 mm) AL was disconnected from its insertion, and a peri-
cardial patch (233 12 mm) was used to extend its height. The second-order
chordae were always cut to provide better mobility of the leaflet. When the
second-order chords tethered the AL excessively, an aortotomy was per-
formed, and these chordae were cut to increase the mobility of the leaflet
(Video E2).
Different techniques were used to exclude ventricular scars. In the case
of inferior scar, an incision parallel to the descending posterior artery was
performed, and the scar was longitudinally excluded with interrupted U su-
tures. If the scar was limited to the apex and to the apical septum, a Dor pro-
cedure (purse-string with or without patch) was used. If the scar involved the
septum more than the anterior free wall, a septal reshaping was performed.7
The purpose of these procedures was always to rebuild a conical shape.
Tricuspid repair was performed with a De Vega suture annuloplasty or
a band annuloplasty.
Follow-up
All patients were clinically followed up in our outpatient clinic 3, 6, and
12 months after surgery and thereafter at yearly intervals. The most recent
informationwas obtained by calling the patient or the referring cardiologists.
Follow-up was 100% complete. Mean follow-up time was 18  6 months.diovascular Surgery c Volume 141, Number 5 1151
FIGURE 1. Algorithm for indications for different surgical procedures.CIMR, Chronic ischemic mitral regurgitation; ERO, effective regurgitant orifice; SL,
systolic septolateral diameter; AL, anterior leaflet; CD, coaptation depth; ESV, end-systolic volume.
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Remodeling, and EF Modifications
Every patient had at least 1 echocardiographic control during the follow-
up. Time from surgery to the last control was 17  5 months (median 18
months). Modifications of the indexed end-diastolic volume and indexed
ESV were evaluated as percentages of the preoperative values. Reverse re-
modeling was defined as any reduction by 15% or more, continuous remod-
eling as any increase by 15% or more, and no remodeling as a modification
of the postoperative value betweenþ14% and14%. EF was considered
improved if the control value increased by 15% or more of its base value,
unchanged if it remained between14.9% andþ14.9%, and worsened if
reduced by more than 15%.
End Points
The primary end points of this study were our clinical and echocardio-
graphic results after an echocardiographically based strategy for the treat-
ment of CIMR.
Statistical Analysis
Results are expressed as mean SD and median values. Categoric vari-
ables are reported as counts and percentages. Echocardiographic modifica-
tions with time were evaluated with the analysis of variance test for repeated
measure (with post hoc analysis). Survival was evaluated by Kaplan–Meier
method. The optimal cutoff was determined by receiver operating character-
istic curve analysis. The influence of preoperative ESV on midterm ventric-
ular remodeling grade was investigated by means of linear regression. The
SPSS software package (SPSS Inc, an IBM Company, Chicago, Ill) was
used.RESULTS
One hundred thirty-seven patients (93.2%) underwent
MV repair, and in 10 (6.8%) a prosthesis was inserted inside1152 The Journal of Thoracic and Cardiovascular Surthe MV, more often in case of ventricular surgery (7/42 vs 3/
105, P ¼ .008). The AL was augmented in 5 cases (3.4%);
in all of them, the second-order chordae were cut. In 7 other
patients, second-order chordae were electively cut through
an aortotomy. Ventricular scar exclusion was performed in
42 cases (28.6%): linear resection of scarred inferior wall
in 7 cases (4.7%), septal reshaping in 29 (19.7%), and
a Dor procedure in 6 (4.2%). In total, 39% of the patients
(57/147) underwent annuloplasty combined with other pro-
cedures. Coronary artery bypass grafting was performed in
135 patients (91.8%) and tricuspid repair in 51 patients
(34.7%).Survival
Seven patients (4.8%) died during the first month. Causes
of death were pulmonary complications in 3 cases, low out-
put syndrome in 2, arrhythmias in 1, and coagulopathy in 1.
After a mean follow-up of 7  3 months, 13 more patients
died of cardiac (n ¼ 7) and noncardiac causes (n ¼ 6).
Mean follow-up of the 127 survivors was 20  9 months.
The 3-year freedoms from death from any cause and from
cardiac-related death were 86%  3% and 90%  3%,
respectively.Functional Results
Mean New York Heart Association (NYHA) functional
class was 1.3  0.5, with 90 patients in NYHA class I, 36
in NYHA class II, and 1 in class III. NYHA functional classgery c May 2011
TABLE 2. Echocardiographic control in 117 patients who underwent mitral valve repair
Postoperative
Preoperative Early Midterm
End-diastolic volume index (mL/m2) 84  24 (79) 71  17 (74)* 67  16 (68)y
End-diastolic volume index (mL/m2) 55  20 (49) 45  14 (42)* 40  12 (38)y,z
Ejection fraction (%) 37  10 (36) 39  9 (38) 43  10 (42)y,z
Sphericity index 0.63  0.09 (0.6) 0.58  0.09 (0.57)* 0.59  0.08 (0.6)y
Tricuspid regurgitation (0–4) 1.4  0.7 (1) 0.7  0.6 (1)* 0.8  0.7 (1)y
Systolic pulmonary arterial pressure (mm Hg) 36  11 (33) 29  5 (29)* 28  8 (28)z
Mitral effective regurgitant orifice (mm2) 34.1  10.2 (33) 1.5  0.1 (0)* 2.3  0.4 (0)y,z
Diastolic intercommissural diameter (mm) 33  3 (33) 27  3 (27)* 27  2 (27)y
Systolic intercommissural diameter (mm) 31  3 (30) 24  2 (24)* 24  3 (24)y
Diastolic septolateral diameter (mm) 30  23 (29) 25  3 (24)* 25  2 (25)y
Systolic septolateral diameter (mm) 28  3 (27) 21  2 (21)* 21  2 (21)y
Diastolic mitral area (cm2) 7.8  1.3 (7.5) 5.3  1.3 (5.2)* 5.3  1.0 (5.3)y
Systolic mitral area (cm2) 6.8  1.2 (6.5) 3.9  1.8 (3.8)* 3.9  0.9 (4.1)y
Mitral area change (%) 12.8  5.2 (15.6) 26.3  4.7 (26.0)* 26.4  3.0 (22.4)y
AL (mm) 27  2 (27)
Septolateral diameter/AL 1.04  0.1 (1) 0.78  0.11 (0.78)* 0.78  0.10 (0.78)y
Tenting area (cm2) 1.50  0.91 (1.3) 0.44  0.25 (0.44)* 0.45  0.27 (0.47)y
Coaptation depth (mm) 7.9  2.4 (8) 4.6  1.9 (4.5)* 4.4  1.8 (4)y
Coaptation length (mm) 3.9  1.4 (4) 4.9  1.7 (5.0)* 5.4  1.5 (5.7)y,z
Functional mitral valve area (cm2) 3.1  0.6 (3) 3.1  0.4 (3.1) 3.0  0.8 (3)
Mean gradient (mm Hg) 3.7  1.0 (3.8) 3.7  2.0 (3.4)
All data are mean  SD and median. Early postoperative period is 1 to 3 months; midterm postoperative period is 18 months. *Preoperative versus early P< .05. yPreoperative
versus midterm P< .001. zEarly versus midterm P< .05. AL, Anterior leaflet.
TABLE 3. Change of mitral regurgitation grade according to the
preoperative mitral regurgitation grade and the early postoperative
mitral regurgitation grade
Preoperative
effective
regurgitant
orifice (mm2)
Effective regurgitant orifice
(mm2) after 18 mo follow-up
0 1–9 10–19  20 Total P value
All
1–9 4 1 — — 5 .852
10–19 9 3 2 — 15
20 68 22 7 — 97
Early
0 78 20 — — 98 <.001
1–9 3 7 9 — 19
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tive change in EF.
Postoperative Echocardiography
All 127 survivors had a postoperative echocardiogram
performed 1 to 3 months after surgery and after a mean
follow-up of 18  6 months. The 10 patients in whom a mi-
tral prosthesis had been inserted were in NYHA class I or II,
and none showed continuous remodeling.
In 117 patients who underwentMV repair (Table 2), mean
ERO changed from 34.1  10.2 mm2 to 2.3  0.4 mm2
(P< .001). In total, 81 patients had no mitral regurgitation,
27 had mitral regurgitation with ERO 1 to 9 mm2, and 9 had
mitral regurgitation with ERO 10 to 19 mm2. No patient had
worsened mitral regurgitation grade. Ninety-eight patients
were discharged from the hospital with no residual mitral re-
gurgitation; only 16 of these showed ERO 1 to 9 mm2 on
follow-up. In contrast, 9 patients of 19 who at discharge
had residual mitral regurgitation with ERO 1 to 9 mm2
showed progression of mitral regurgitation (Table 3). Free-
dom from both death from any cause and from mitral regur-
gitation with ERO at least 10 mm2 was 83%  5%.
The 20 patients who died had undergone postoperative
echocardiography from 3 days to 7 months after surgery.
All of them had no (n ¼ 13) or residual mitral regurgitation
with ERO 1 to 9 mm2 (n¼ 7), mean 1.8 0.3. Patients who
died in the first 30 days had a trend toward lower ventricular
volumes than seen in patients who survived the first 30 daysThe Journal of Thoracic and Car(end-diastolic volume 66  23 mL/m2 vs 82  26 mL/m2
and ESV 42  18 mL/m2 vs 53  22 mL/m2).Ventricular Remodeling
Of the 117 patients who underwent MV repair, 69
(59.0%) had reverse remodeling occur, 40 (34.1%) had
no remodeling occur,and 8 (6.9%) had continuous remodel-
ing occur. No patient who showed reverse remodeling had
mitral regurgitation progression to ERO of at least 10 mm2
(0/69), whereas the incidences of such progression were
7.5% when no remodeling occurred (3/40) and 75% (6/8)
if remodeling continued, (P < .001). Remodeling wasdiovascular Surgery c Volume 141, Number 5 1153
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istic curve showed a cutoff at 60 mL/m2) and by low pre-
operative EF (Table 4).
Comparing early (1 to 3 months) and late ESV modifica-
tion, none of the patients who showed no remodeling or re-
verse remodeling had worsening to continuous remodeling.EF Modifications
EF improved in 47 cases, remained unchanged in 63, and
worsened in 7. Only in 68 patients (Table E2) did ventricular
remodeling and EF modifications coincide, whereas in 49
the modifications were dissimilar, with patients with reverse
remodeling showing no EF change. Comparing early and
late EF modifications, no patient with early improvement
had late worsening.Mitral Prosthesis Insertion
In 10 patients, a mitral prosthesis was inserted because
CD was greater than 10 mm. Preoperatively, these patients
showed a trend toward a higher indexed ESV (67  18 vs
54  22, P ¼ .07), whereas EF (31%  5% vs 35% 
9%, difference not significant) and ERO (39  8 mm2 vs
36  11 mm2, difference not significant) did not differ
from those in the rest of the population. All patients survived
and were in NYHA class I (n¼ 8) or II (n¼ 2) at follow-up.
Seven patients showed reverse remodeling, and 3 showed no
remodeling.DISCUSSION
The main findings of this study were as follows: (1) Close
to 40% of the patients who underwent MV surgery for
CIMR underwent more than isolated annuloplasty. (2) Re-
verse remodeling is frequent and is more frequent among pa-
tients with larger volumes and lower EF. (3) In the midterm,
functional results did not depend on ventricular remodeling
or on EF changes. (4) Patients who were discharged with no
residual mitral regurgitation did not show mitral regurgita-
tion grade with ERO of at least 20 mm2 at follow-up.TABLE 4. Factors influencing ventricular remodeling
Remodeling
Reverse None Continuous Total P value
End-systolic volume
60 mL/m2 35 4 1 40 <.001
<60 mL/m2 34 36 7 77
Postoperative effective regurgitant orifice
0–9 mm2 69 37 2 108 <.001
10 mm2 0 3 6 9
Preoperative ejection fraction
30% 30 8 3 41 .011
31–40% 17 6 3 26
>40% 22 26 2 50
1154 The Journal of Thoracic and Cardiovascular SurThe natural history of CIMR is not favorable. The pres-
ence of CIMR after myocardial infarction has been demon-
strated to be related to lower survival, in particular when
ERO is at least 20 mm2.5 The excess mortality was indepen-
dent of both the EF and the functional status. Any grade of
CIMR, as measured by ERO, has been seen to be related
at 5 years to higher incidences of congestive heart failure
and of the combined end points of congestive heart failure
and cardiac-related death.8 CIMR left untreated when coro-
nary artery bypass grafting was performed has also been
shown to be followed by a worse long-term outcome. Our
group previously demonstrated that results of coronary ar-
tery bypass grafting alone in patients with CIMR 2þwere
poor if EF was no greater than 30%,9 and freedoms from
cardiac-related death and from cardiac events were reduced
in patients with EF 31% to 40% and CIMR 1þor 2þ.10
On the basis of these observations, some patientswithmild
CIMR could benefit fromMV repair. To identify such a sub-
group, we prefer to address echocardiographicMV anatomy.
When septolateral dimension or the ratio of septolateral di-
mension toAL length is equal or superior to themedian value
of patients with CIMR that is moderate or worse (27 mm and
1.02, respectively), we hypothesize that MV anatomy is ab-
normal and that further worsening is more likely to happen
than in patients with mild CIMR and less abnormal mitral di-
mensions. The clinical impact of this problem is, however,
very limited, because only 5 patients with ERO between 1
and 9 mm2 were surgically treated.
The basic technique to repair functional CIMR is down-
sizing annuloplasty, introduced by Bolling and colleagues.11
Even if the same authors12 were not able to demonstrate any
benefit in survival when comparing treated and untreated pa-
tients, others13 found annuloplasty to improve the clinical
status. The main problem of the surgical treatment of
CIMR, however, is mitral regurgitation’s return (or residual
mitral regurgitation), being present, with different percent-
ages in all the reports.14-16 Annuloplasty alone is not the
only option for surgical treatment of CIMR; in close to
40% of our patients, additional solutions were applied.
CIMR is a ventricular disease, because the mechanism of
closure of the MV is affected by displacement of the poster-
omedial (asymmetric displacement) or both (symmetric
displacement) papillary muscles. Consequences of these
changes are regurgitation of different grade and deepening
of the CD. There is a range of anatomic and functional mod-
ifications of the MV which still allows to correct the regur-
gitation, with overreductive annuloplasty, combining or
not with other techniques. There is, however, a cutoff point
at which conservative techniques do not pay in the midterm
or long term. Different indicators (CD,6 degree of papillary
muscle displacement,17 angles between the posterior18 or
anterior19 mitral leaflets and the annular plane) were used
as surrogates for the ventricular modifications that could sus-
tain mitral regurgitation return.gery c May 2011
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group proposed that a CD of 10 mm be used as cutoff point
to separate cases in which MV repair could be performed
from those in which chordae-sparing implantation of a pros-
thesis was the preferable solution.6 Long-term survivals
among patients who underwent MV repair and replacement
were found to be similar by Al-Radi and coworkers20 and
Magne and associates.21
When the AL length is shorter than 25 mm, augmentation
of the leaflet can be obtained with a pericardial patch, as sug-
gested by Kinkaid and colleagues,22 to increase the CL.
When the AL was augmented, the second-order chordae
were always cut, to increase the mobility of the leaflet. Selec-
tive chordal cutting was performed in 7 cases, because lim-
itation of AL excursion will reduce the CL. Even if chordal
cutting is still controversial, our results were excellent, at
least in the midterm.
In our opinion, ventricular scar exclusion, when possible,
can be a valid tool to increase the benefit of MV surgery.
Ventricular scarring, as demonstrated by Srichai and co-
workers,23 is significantly increased in patients with severe
CIMR. Braun and colleagues15 showed reduced survival
and lack of reverse ventricular remodeling among patients
with diastolic left ventricular dimensions greater than 65
mm. They advocated, for these patients, a concomitant ven-
tricular approach. Other studies have emphasized the neces-
sity of adding some ventricular procedure in case of enlarged
cardiac dimensions.19 We believe that, in the presence of in-
creased left ventricular volumes, ventricular scar exclusion
is part of the surgical strategy for CIMR treatment to prevent
mitral regurgitation return.
Applying all these technical solutions, reverse remodeling
was present in 59% of the survivors who underwent mitral
repair, and only 6.9% showed continuous remodeling. It is
debatable whether the result can be considered favorable
when no remodeling is present, because maintaining a simi-
lar systolic function without, or with less, mitral regurgita-
tion could have a positive effect on long-term results;
however, only patients with reverse remodeling showed no
or mild residual mitral regurgitation. Reverse remodeling
was more likely to happen in patients with larger volumes
and lower EF, but it is noteworthy that, independent of the
quality of remodeling, functional results are good, at least
in the midterm.
Interestingly, only patients discharged with mild mitral re-
gurgitation (ERO 1–9 mm2) showed further mitral regurgi-
tation progression from mild to moderate. It is still not
clear whether something different from isolated annulo-
plasty could further reduce the incidence of moderate or se-
vere mitral regurgitation in the follow-up. Magne and
coworkers18 showed that a posterior leaflet angle of at least
45 predicted mitral regurgitation return, even if CD was 10
mm or less. Perhaps this parameter could be helpful in iden-
tifying more patients in whom annuloplasty alone has to beThe Journal of Thoracic and Carabandoned. Very likely a larger use of MV prosthetic inser-
tion would contribute to improved long-term results; sur-
geons are still reluctant, however, because this is
considered a surgical failure.
Downsizing annuloplasty was obtained with a flexible
40-mm long band. Because use of a device to reshape the
annulus is crucial, we decided to respect at maximum the
morphologic and functional properties of the mitral annulus,
maintaining the systodiastolic narrowing of the annulus (to
reduce the gradients in diastole and to increase the coapta-
tion in systole; Table 2) and its saddle shape (which reduces
the stress on the leaflets and keeps the AL in a preopening
position; Figure E1). Similar findings have been reported
by others.24 Caimmi and colleagues,25 comparing in a mag-
netic resonance imaging study partial flexible (SMB40 and
SMB50) and rigid complete (St Jude, saddle ring) circumfer-
ential rings, found that left ventricular outflow dynamics and
AL movements are significantly impaired when a rigid cir-
cumferential ring is used, blocking the lower part of the aor-
tomitral membrane physiologic movement. These changes
are not present when the SMB40 or SMB50 is used.
The use of the same size band for every patient facilitates
surgery but needs further comments. The rationale is based
on the fact that the septolateral distance we achieve with
the SMB40 is 21 mm. Because the length of the AL has
small variability (mean 27.5  2.3 mm and median 27
mm, with only a few patients having an AL length<25
mm). in the great majority of cases such a band will allow
a good CL of 5 mm or more. In the remaining cases, AL aug-
mentation will be able to obtain again a longer CL. Anyway,
in most series only 1 or 2 sizes (ring or band) are practically
used.
Limitations of the Study
This was a retrospective study, but it included all the pa-
tients who underwent CIMR, independent of the location of
the myocardial infarction, as it happens in the real world.
Mean EF was only 35%, but a third of the patients had
EF of 30% or less, mirroring the EF distribution in the
real world. The anatomic and functional aspects of the
MV were different, just as are the functional consequences
of ventricular disease on the pathophysiology of the MV.
The follow-up was relatively short, but most of the adverse
outcomes after surgery for functional CIMR are seen in the
early follow-up. The main weakness of this study is the lack
of a control group; this reduces the possibility of validating
correctly the algorithm that we propose. A large variety of
surgical approaches were used on relatively small number
of patients. Although this probably reflects the complexity
of this disease process and the lack of consensus regarding
its treatment, it also significantly reduces our ability to make
scientifically valid conclusions from our data. Myocardial
viability was not routinely assessed, because regional wall
abnormalities together with myocardial infarction in thediovascular Surgery c Volume 141, Number 5 1155
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Dsame area made the study not necessary. We are aware that
this may affect our conclusions on postoperative left ven-
tricular remodeling and functional mitral regurgitation
recurrence.
CONCLUSIONS
In conclusion, surgery for CIMR must consider the mech-
anisms and the effects of the underlying ventricular disease
on the MV. Fewer than 10% of patients need prosthetic in-
sertion. In the remaining cases repair can be performed, but
only a careful observation of the echocardiographic anatomy
of theMV can dictate the most appropriate technique for sur-
gical correction of CIMR.
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FIGURE E1. Three -dimensional reconstruction of mitral annulus 2 years
after surgical correction of chronic ischemic mitral regurgitation with
SMB40. Saddle shape of mitral annulus is maintained. Transesophageal
echocardiographic study was performed with Acuson Sequoia C 512 (Sie-
mens, Munich, Germany) equipped with Tomtec software (Tomtec Imaging
Solution, Unterschleissheim, Germany). ant, Anterior annulus; post, poste-
rior annulus.
TABLE E1. Systolic septolateral diameter and systolic septolateral
diameter/anterior leaflet length ratio according the preoperative
effective regurgitant orifice
Preoperative effective
regurgitant orifice (mm2) SSL (mm)
SSL/anterior leaflet
length ratio
1–9 28.7  2.5 (28.5) 1.03  0.11 (1.04)
10–19 27.6  3.5 (27) 1.04  0.15 (1.00)
20 27.7  2.5 (27) 1.04  0.12 (1.04)
10 27.6  2.6 (27) 1.04  0.13 (1.02)
Data are expressed as mean  SD and median. SSL, Systolic septolateral diameter.
TABLE E2. Modification of ejection fraction compared with
ventricular remodeling
Left ventricular remodeling
Ejection fraction Reverse None Continuous
Improved (15%) 39 7 1
Stable (14.9% toþ14.9%) 27 29 7
worsened (15%) 3 4 —
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